Home Videos How Value Investors Can Evaluate Bio-Tech Companies [VIDEO]

How Value Investors Can Evaluate Bio-Tech Companies [VIDEO]

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

Value investors are well aware that investing in technology companies is not an easy task. Additionally, valuing bio-tech companies is far more difficult. The Manual of Ideas conducted an interview with Humphrey Nokes of Cygna Negra, on this very topic. Nokes discusses how value investors can evaluate bio-tech companies in this video interview:

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.